In this invention a new compound, a ligand to the peripheral-type benzodiazepine receptor (PBR), is introduced. The PBR-ligand attachment induces anti-apoptotic activity, which is of extreme value in neurodegenerative diseases and traumatic brain damage. Traumatic brain injury is the leading cause of disability in individuals below the age of 40.